Skip to main content
OpenTrials
Completed

NCT Number: NCT03883737

Percutaneous Neuromodulation on the Anterior Pain Knee

Anterior knee pain (AKP) is one of the most frequent pathologies of the lower limb, in young and adult subjects. In the field of Physiotherapy, ultrasound-guided Percutaneous Neuromodulation (PNM) is defined as the application through a needle with ultrasound guidance of an electrical current at low or medium frequency, seeking a sensitive and / or motor response of a peripheral nerve in some point of its trajectory, or of a muscle in a motor point, with a therapeutic objective. The objective of this study is to analyze that the effect of PNM on the femoral nerve produces statistically significant changes in pain, joint range and knee functionality in patients with chronic AKP. Thirty subjects will be recruited, which will be divided into 2 groups: group 1 to which PNM will be applied to the femoral nerve of the pain knee; and group 2 to which PNM will be applied to the femoral nerve of the non-pain knee. The PNM intervention with NMP will consist in the single application of an asymmetric rectangular biphasic current (250 microseconds, 10 Hz)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Neuromodulation Anterior Pain Knee Femoral Nerve

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Seville

Seville, 41010, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • chronic anterior knee pain >3 months
  • older than 18 years-old

Exclusion criteria

  • Surgical intervention in the intervention area
  • Prosthesis or osteosynthesis in the intervention area
  • Cardiac or tumoral diseases
  • Coagulopathies
  • Be under the effects of certain medications
  • contraindication characteristic of the puncture

Treatment and study plan

PNM

Other

an asymmetric rectangular biphasic current (250 microseconds, 10 Hz)

Primary outcomes

  1. visual analog scale (VAS) (0, no pain; 100, maximum pain).

    Time frame: up to 1 week

    pain

  2. range joint

    Time frame: up to 1 week

    goniometer

  3. VISA-p questionnaire (0, maximum pain; 100, no pain).

    Time frame: up to 1 week

    Functional pain

  4. Kujala questionnaire (0, maximum pain; 100, no pain).

    Time frame: up to 1 week

    Functional pain

Sponsors and collaborators

Lead sponsor

University of Seville

Other

Registry information

Official study title

Effect of the Ultrasound-guided Percutaneous Neuromodulation on the Anterior Pain Knee: a Pilot Study

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Mar 21, 2019
Registry last updated
Jul 14, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.